By using SoloCheck.co.uk you consent to the use of cookies in accordance with our cookie policy. See our Cookie Policy.

DESTINY PHARMA (BRIGHTON) LIMITED


1 view

Summary


DESTINY PHARMA (BRIGHTON) LIMITED was set up on Thursday, December 8, 2016. Their current partial address is UNIT 36 SUSSEX INNOVATION CENTRE and the company status is Active - Proposal to Strike off.

Credit Score


Latest Accounts Filed:

31/12/2022

Next Set of Accounts Due:

30/09/2024

Company Vitals


Company Name:

DESTINY PHARMA (BRIGHTON) LIMITED

Time in Business:

8 years

Company Number:

10517676

Current Status:

Active - Proposal to Strike off

Company Category:

Private Limited Company

Country of Origin:

United Kingdom

Principal Activity:

[99999] - Dormant Company

Registered Address:

UNIT 36 SUSSEX INNOVATION CENTRE
SCIENCE PARK SQUARE
FALMER
BRIGHTON
UNITED KINGDOM
BN1 9SB

Previous Names:

DESTINY PHARMA LIMITED
DESTINY PHARMA (BRIGHTON) LIMITED

Filing History


Submission Date Type
Gazette dissolved compulsory 2025-06-24 GAZ2
Dissolved compulsory strike off suspended 2025-01-14 DISS16(SOAS)
Gazette notice compulsory 2024-12-10 GAZ1
Confirmation statement with no updates 2023-12-20 CS01
Accounts with accounts type dormant 2023-06-28 AA
Appoint person director company with name date 2023-06-06 AP01
Termination director company with name termination date 2023-06-06 TM01
Confirmation statement with no updates 2022-12-14 CS01
Accounts with accounts type dormant 2022-07-20 AA
Confirmation statement with updates 2021-12-10 CS01
Accounts with accounts type dormant 2021-05-25 AA
Confirmation statement with no updates 2020-12-08 CS01
Accounts with accounts type dormant 2020-05-27 AA
Confirmation statement with no updates 2019-12-04 CS01
Accounts with accounts type dormant 2019-05-03 AA
Confirmation statement with no updates 2018-12-14 CS01
Termination director company with name termination date 2018-10-25 TM01
Accounts with accounts type dormant 2018-10-16 AA
Confirmation statement with updates 2017-12-14 CS01
Change to a person with significant control 2017-12-14 PSC05